September 17, 2019
  • September 17, 2019
Breaking News
  • Home
  • Technology
  • Tesla Motors Inc (NASDAQ:TSLA) request approved to waive 10 percent tariffs on imported aluminum from Japan

Tesla Motors Inc (NASDAQ:TSLA) request approved to waive 10 percent tariffs on imported aluminum from Japan

By on June 25, 2019 0

The US Commerce Department has agreed to Tesla Motors Inc (NASDAQ:TSLA)’s request to waive 10 percent tariffs on imported aluminum from Japan used in the manufacture of battery cells at Tesla’s Nevada Gigafactory, government documents show. The Palo Alto, California-based company made the request in documents posted in April and said the aluminum is produced by Nippon Light Metal Co Ltd and was seeking a tariff exclusion for 10,000 tonnes annually.

Tesla Motors Inc (NASDAQ:TSLA), a Consumer Goods sector firm, traded 5.74 Million shares in last trading session with closing price of $223.64 per share. Company gross margin stands at 18.40% whereas its return on investment (ROI) is -2.60%. Stock value has moved between $177.49 – 385.59 in last one year. Analyst’s mean target price for Tesla Motors Inc (NASDAQ:TSLA) is $280.31 while analysts mean recommendation is 2.90. TSLA EPS growth this year is 23.40%. 

On last trading day, Kinder Morgan, Inc. (NYSE:KMI) shares closed at $21.16 per share. KMI market capitalization is 47273.56 with beta of 0.84. Analyst’s mean target price for Kinder Morgan, Inc. (NYSE:KMI) is $21.65 whereas analysts mean recommendation is 2.10. Its weekly performance is 3.12% while year to date (YTD) performance is 37.58%. 

In last session HealthEquity, Inc. (NASDAQ:HQY) traded 606964 shares and was closed at $66.56. Analyst’s mean target price for HQY is $87.00 while analysts mean recommendation is 1.80. Company is -34.48% away from its 52 week high and is moving 32.35% ahead of its 52 week low. HQY Gross Margin is 63.90% and its return on assets is 18.30%. HealthEquity, Inc. (NASDAQ:HQY) quarterly performance is -9.53% while its price to sale ratio is 13.80. 

InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV), a Healthcare sector firm, traded 6523 shares on last trading day with closing price of $0.76 per share. Stock value has moved between $0.65 – 2.71 in last one year. Analyst’s mean target price for InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) is $4.60. NVIV EPS growth this year is 76.90%. 

Leave a comment